SEC EDGAR Filing Information

Form 3 -- Initial statement of beneficial ownership of securities

Period of Report: 2009-03-27
Filing Date Changed: 2009-03-30
Documents: 1

SEC Accession No.
0001140361-09-008242
Filing date: 2009-03-30
Accepted: 2009-03-30 16:01:46

Table of submitted documents:

Seq	Type	Document	Size	Description
1	3	doc1.html		FORM 3
1	3	doc1.xml	1657	FORM 3

		0001140361-09-008242.txt	3601	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Issuer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
29 EMMONS DRIVE
SUITE C-10
PRINCETON NJ 08540
609-452-0001

Mailing Address
29 EMMONS DRIVE
SUITE C-10
PRINCETON NJ 08540

Brey Robert N (Reporting) (0001459724)
Type: 3 | Act: 34 | File No.: 000-16929 | Film No.: 09714230

Business Address

Mailing Address
850 BEAR TAVERN ROAD
SUITE 201
EWING NJ 08628